This activity was developed for a national audience of family medicine physicians, and other healthcare professionals who work in the family medicine/primary care setting.
This case-based activity touches on the diagnostic and clinical challenges faced in the primary care management of patients with chronic hyperkalemia with suggestions for integrating the evolving options into practice to improve patient outcomes.
Upon completion of this activity, participants should be better able to:
- List common causes of hyperkalemia
- Describe the clinical benefits of renin-angiotensin-aldosterone system inhibitor (RAASi) therapy in patients with chronic kidney disease and heart failure
- Compare and contrast patiromer and sodium zirconium cyclosilicate for the treatment of chronic hyperkalemia, including safety and efficacy data
- Identify opportunities to treat patients with potassium-binding agents, in accordance with the latest guidance, to help optimize the use of RAASi therapy